— Know what they know.
Not Investment Advice

LCI NYSE

Lannett Company, Inc.
1W: +47.4% 1M: -79.3% 3M: -98.7% 1Y: -99.6% 3Y: -100.0% 5Y: -100.0%
$0.69
Last traded 2023-05-23 — delisted
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · $7.4M mcap · 8M float · 2.48% daily turnover

Balance Sheet Trends

Total Assets
$484M -29.1% ▼
5Y CAGR: -21.3%
Total Liabilities
$735M +3.4% ▲
5Y CAGR: -6.7%
Shareholders Equity
-$251M -813.9% ▼
Cash & Investments
$88M -5.8% ▼
5Y CAGR: -9.5%
Total Debt
$627M +3.8% ▲
5Y CAGR: -7.0%
Net Debt
$539M +5.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$99M$140M$144M$93M$88M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$99M$140M$144M$93M$88M
Net Receivables$253M$165M$140M$134M$56M
Inventory$142M$144M$143M$110M$95M
Other Current Assets$34M$14M$13M$14M$51M
Total Current Assets$527M$472M$443M$354M$290M
Property, Plant & Equip.$233M$187M$189M$177M$143M
Goodwill & Intangibles$764M$411M$375M$138M$32M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$29M$8M$12M$15M$19M
Total Non-Current Assets$1.0B$715M$693M$330M$194M
Total Assets$1.6B$1.2B$1.1B$684M$484M
— Liabilities —
Accounts Payable$13M$13M$33M$30M$30M
Short-Term Debt$67M$67M$89M$2M$2M
Deferred Revenue$0$90M$90M$57M$0
Other Current Liabilities$77M$6M$93M$59M$73M
Total Current Liabilities$201M$177M$215M$90M$105M
Long-Term Debt$772M$662M$603M$602M$625M
Other Non-Current Liab.$3M$15M$16M$19M$6M
Total Non-Current Liabilities$775M$677M$619M$621M$631M
Total Liabilities$976M$853M$834M$711M$735M
— Equity —
Common Stock$38K$39K$40K$41K$42K
Retained Earnings$306M$32M-$1M-$365M-$596M
Accumulated OCI-$515K-$615K-$627K-$548K-$411K
Total Stockholders Equity$599M$334M$303M-$27M-$251M
Total Liabilities & Equity$1.6B$1.2B$1.1B$684M$484M
— Key Metrics —
Total Debt$839M$729M$692M$604M$627M
Net Debt$741M$589M$548M$510M$539M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms